PI3K110α (the catalytic subunit of class I PI3K) has been considered as the only relevant catalytic subunit in the context of cancer associated mutations [64] and has shown relevant anti-tumor potential in pancreatic NETs in vitro and in vivo [18, 65]. The gene discussed is PIK3CA; the disease is neoplasm.